These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
400 related articles for article (PubMed ID: 21128824)
1. Pharmacokinetic evaluation of colistin sodium. Michalopoulos AS; Karatza DC; Gregorakos L Expert Opin Drug Metab Toxicol; 2011 Feb; 7(2):245-55. PubMed ID: 21128824 [TBL] [Abstract][Full Text] [Related]
2. [Shedding light on the use of colistin: still gaps to be filled]. Luque S; Grau S; Berenguer N; Horcajada JP; Sorlí L; Montero MM; Salas E Enferm Infecc Microbiol Clin; 2011 Apr; 29(4):287-96. PubMed ID: 21440335 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria. Li J; Nation RL; Milne RW; Turnidge JD; Coulthard K Int J Antimicrob Agents; 2005 Jan; 25(1):11-25. PubMed ID: 15620821 [TBL] [Abstract][Full Text] [Related]
4. Differences in pharmacokinetics and pharmacodynamics of colistimethate sodium (CMS) and colistin between three different CMS dosage regimens in a critically ill patient infected by a multidrug-resistant Acinetobacter baumannii. Luque S; Grau S; Valle M; Sorlí L; Horcajada JP; Segura C; Alvarez-Lerma F Int J Antimicrob Agents; 2013 Aug; 42(2):178-81. PubMed ID: 23769664 [TBL] [Abstract][Full Text] [Related]
5. Colonization and infection by colistin-resistant Gram-negative bacteria in a cohort of critically ill patients. Kontopidou F; Plachouras D; Papadomichelakis E; Koukos G; Galani I; Poulakou G; Dimopoulos G; Antoniadou A; Armaganidis A; Giamarellou H Clin Microbiol Infect; 2011 Nov; 17(11):E9-E11. PubMed ID: 21939468 [TBL] [Abstract][Full Text] [Related]
6. Intravenous colistin for multidrug-resistant gram-negative infections in critically ill pediatric patients. Kapoor K; Jajoo M; Dublish S; Dabas V; Gupta S; Manchanda V Pediatr Crit Care Med; 2013 Jul; 14(6):e268-72. PubMed ID: 23689704 [TBL] [Abstract][Full Text] [Related]
7. Colistin pharmacokinetics: the fog is lifting. Couet W; Grégoire N; Marchand S; Mimoz O Clin Microbiol Infect; 2012 Jan; 18(1):30-9. PubMed ID: 21988234 [TBL] [Abstract][Full Text] [Related]
8. Colistin in critically ill patients. Boisson M; Gregoire N; Couet W; Mimoz O Minerva Anestesiol; 2013 Feb; 79(2):200-8. PubMed ID: 23241733 [TBL] [Abstract][Full Text] [Related]
9. Multidrug-resistant Gram-negative infections: the use of colistin. Michalopoulos AS; Karatza DC Expert Rev Anti Infect Ther; 2010 Sep; 8(9):1009-17. PubMed ID: 20818945 [TBL] [Abstract][Full Text] [Related]
10. Polymyxins for the treatment of extensively-drug-resistant Gram-negative bacteria: from pharmacokinetics to bedside. Zavascki AP Expert Rev Anti Infect Ther; 2014 May; 12(5):531-3. PubMed ID: 24666285 [TBL] [Abstract][Full Text] [Related]
11. Polymyxin B: similarities to and differences from colistin (polymyxin E). Kwa A; Kasiakou SK; Tam VH; Falagas ME Expert Rev Anti Infect Ther; 2007 Oct; 5(5):811-21. PubMed ID: 17914915 [TBL] [Abstract][Full Text] [Related]
12. Aerosolized colistin for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis. Michalopoulos A; Kasiakou SK; Mastora Z; Rellos K; Kapaskelis AM; Falagas ME Crit Care; 2005 Feb; 9(1):R53-9. PubMed ID: 15693967 [TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of intravenous colistin (colistin methanesulphonate) for severe multidrug-resistant Gram-negative bacterial infections. Cheng CY; Sheng WH; Wang JT; Chen YC; Chang SC Int J Antimicrob Agents; 2010 Mar; 35(3):297-300. PubMed ID: 20045293 [TBL] [Abstract][Full Text] [Related]
14. Colistin and polymyxin B in critical care. Michalopoulos A; Falagas ME Crit Care Clin; 2008 Apr; 24(2):377-91, x. PubMed ID: 18361952 [TBL] [Abstract][Full Text] [Related]
15. Intravenous colistin sulfate: a rarely used form of polymyxin E for the treatment of severe multidrug-resistant Gram-negative bacterial infections. Huang J; Tang YQ; Sun JY Scand J Infect Dis; 2010 Apr; 42(4):260-5. PubMed ID: 20085424 [TBL] [Abstract][Full Text] [Related]
16. [Clinical assessment of colistin in treating infections caused by multidrug-resistant gram-negative bacillus in patients with severe burn]. Zhang JP; Yang XS; Chen J; Peng YZ; Huang YS Zhonghua Shao Shang Za Zhi; 2009 Oct; 25(5):372-6. PubMed ID: 19951562 [TBL] [Abstract][Full Text] [Related]
17. Intravenous colistin sulphomethate sodium for therapy of infections due to multidrug-resistant gram-negative bacteria. Pintado V; San Miguel LG; Grill F; Mejía B; Cobo J; Fortún J; Martín-Dávila P; Moreno S J Infect; 2008 Mar; 56(3):185-90. PubMed ID: 18280570 [TBL] [Abstract][Full Text] [Related]